1 / 58

IgG and IgM based immunopathological reaction (reaction of hypersensitivity type II).

IgG and IgM based immunopathological reaction (reaction of hypersensitivity type II). = antibody-dependent. antibodies produced by the immune response bind to antigens on the patient's own cell surfaces. intrinsic ("self" antigen, innately part of the patient's cells).

charo
Télécharger la présentation

IgG and IgM based immunopathological reaction (reaction of hypersensitivity type II).

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. IgG and IgM based immunopathological reaction (reaction of hypersensitivity type II). • = antibody-dependent • antibodies produced by the immune response bind to antigens on the patient's own cell surfaces • intrinsic ("self" antigen, innately part of the patient's cells) • extrinsic (absorbed onto the cells during exposure to some foreign antigen, possibly as part of infection with a pathogen) • These cells are recognized by macrophages or dendritic cells which act as antigen presenting cells, this causes a B cell response where antibodies are produced against the foreign antigen.

  2. IgG and IgM based immunopathological reaction (reaction of hypersensitivity type II) • Autoimmune hemolytic anemia • Goodpasture's syndrome • Autoimmune pernicious anemia • Immune thrombocytopenia • Transfusion reactions • Myasthenia gravis • Rheumatic fever • Acute transplant rejection

  3. Immune complex based immunopathological reaction (reaction of hypersensitivity type III) • occurs when antigens and antibodies are present in roughly equal amounts, causing extensive cross-linking • large immune complexes that cannot be cleared are deposited in vessel walls and induce an inflammatory response • the reaction can take hours, days, or even weeks to develop

  4. Immune complex based immunopathological reaction (reaction of hypersensitivity type III) Some clinical examples: • Rheumatoid arthritis • Immune complex glomerulonephritis • Serum sickness • Subacute bacterial endocarditis • Systemic lupus erythematosus • Farmer's lung (Arthus-type reaction) • Polyarteritis nodosa

  5. PRIMARY IMMUNODEFICIENCY clinical manifestactions examples

  6. IMMUNODEFICIENCY • Primary immunodeficiencies - congenital, genetically defined disorders - onset of symptoms - predominantly at an early age • Secondary immunodeficiencies - caused by chronic infections, irradiation, injuries, immunosupression therapy, surgery, stress - disorders appear at any age

  7. IMMUNIDEFICIENCY • Humoral deficiency disorders = the B cell deficiency disorders – the qualitative or quantitative defects of the B cells, present 70% of IDs • T cell deficiency disorders and the combined B-cell and T-cell deficiency disorders (20%) – group of the qualitative or quantitative defects of the T and B cells • Phagocytic celldisorders– group of the qualitative or quantitative defects of the fagocytic cells (10%) • Complement disorders – caused by the deficiency of the complement components or functions (<1%)

  8. MAJOR CLINICAL FEATURES • Humoral deficiency disorders - manifest as the recurrent bacterial sinopulmonary and gastrointestinal infections - caused by streptococcus, staphylococcus, haemophilus, begin when infants are 5-9 months of age • T cell disorders - manifest as the recurrent bacterial, fungal and viral respiratory and gastrointestinal infection • Complement disorders – are associated with increased incidence of the infections and autoimmune diseases and with edema in the case of hereditary angioedema • Phagocytic celldisorders – characterized by recurrent infections caused by various organisms incluging abscesses, purulent skin infections, granulomatousinflammations

  9. HUMORAL DEFICIENCY DISORDERS • Bruton’s X-linkedhypogamaglobulinemia • CVID - Common Variable ImmunoDeficiency • Selective immunoglobulin A deficiency <0,07 g/l

  10. Bruton’s X-linkedhypogamaglobulinemia • the genetic defect on the X chromosome leads to the defective function of a tyrosine kinase in the B cells • This defect result in a block of the pre-B cells maturation into the B cells with surface IgM • the immunologic findings: < 2% circulating B cells - low serum levels of all classes of immunoglobulins - number and function of T cells are intact - pre-B cells are in the bone marrow • features : begining from 5-9 months of age - manifests as recurrent bacterial sinopulmonary and gastrointestinal infection caused by streptococcus, staphylococcus, haemophilus, meningococcus, salmonella, campylobacter, giardia • Treatment consists of life-long intravenous pooled human gammaglobulin replacement and antibiotics.

  11. Common VariableImmunoDeficiency • the B cell functional disorder characterized by the normal number of the B cells, low levels of IgG and IgA, a poor response to all vaccines and decrease of the T cells (CD4+) number and function • the symptom’s onset between 2ndand 3rddecade • the clinical features: - recurrent respiratory tract infections (pneumonia), cutaneous and gastrointestinal infection - disease is accompanied by occurrence of the granulomas, lymphadenopathy, splenomegaly • Treatment consist of the intramuscular or intravenous gammaglobulin replacement.

  12. Selective deficiency of IgA • level of IgA up to 0,05 g/l, age > 4 years • the most frequent primary ID - stem cell defect - repeated infections of respiratory tract - susceptibility to autoimmune disorders, malignant disorders, allergy - contra-indication of administration of drug with IgA

  13. T cell deficiency disorders • DiGeorge syndrome - the genetic defect on the chromosome 22 leads to disorder of development of 3rdand 4thbranchial pouch with congenital hypoplasia of both the thymus and parathyroid glands - patients suffer from disorder of pre-thymocytes maturation due to absence/hypoplasia of thymus - syndrome CATCH 22: cardiac defects, abnormal facies, thymic hypo/aplasia, cleft palate, hypocalcemia, deletion 22q11.2 - the symptom’s onset soon after the birth – hypocalcemic spasms andmanifestations of congenital heart disease - treatment: symptomatic, transplantation of a thymus

  14. PRIMARY FAGOCYTIC CELL DEFECTS Chronic granulomatous disease - X- linked recesive disorder - leads to defect in neutrophilic cytochrome b with suppresion of intracellular killing of ingested microorganisms - normal number of leucocytes - infection of catalase-positive bacterias - symptoms appear in the first year of age: pyogenic cutaneous infections, abscesses, granulomas in many organs, pyogenic lymphadenitis - treatment: long-term ATB administration, interferon gamma, corticosteroids

  15. COMPLEMENT DEFICIENCY • C2, C3, C4 complement components deficiencies - lead to an impaired opsonization, susceptibility to infections, autoimune diseases • C6, C7, C8, C9complement components deficiencies - lead to the autoimmune diseases – SLE, RA, sclerodermia and to the neisserial infection • MBLdeficiencies - lead to the respiratory infections and susceptibility to the autoimune and allergy diseases • Treatment: vaccination, ATB

  16. HEREDITARY ANGIOEDEMA pathophysiology clinical manifestations treatment

  17. HEREDITARY ANGIOEDEMA • the congenital AD complement disorder cased by the defect on the chromosome 11 • leads to absence orfunctional deficiency of C1-inhibitor • C4 a C2 complement components show a low level during atack • Type I - occurs in 85% - an absence of C1-inhibitor • Type II - occurs in 15% - a functional deficiency of C1-inhibitor • Secondary - SLE, lymfoma

  18. HEREDITARY ANGIOEDEMA • C1 esterase inhibitor deficiency leads to uncontrolled C1 activity and resultant production of a kinin that increases capillary permeability • Clinical feature: transient recurrent localized edema • the triggering factors: injuries or surgical/stomatological operations • more offen occures in pregnancy • laryngeal edema could be life-threatening, immediate treatment is necessary !

  19. TREATMENT • Preventive – consist of an administration of androgens, a-fibrinolytics - before operation is necessary C1-INH concentrate or a fresh frozen plasma administration - stomatology procedures are performed in hospital • Immediate - C1-INH concentrate or fresh frozen plasma administration • tracheotomy in severe larynx edema • treatment with ACE inhibitorsis contraindicated

  20. ACQUIRED IMMUNODEFICIENCIES causes mechanisms involved AIDS

  21. ACQUIRED IMMUNODEFICIENCIES • Acute and chronic viral infections – EBV, CMV, herpetic virus, influenza, HIV • Metabolic disorders– diabetes, renal failure, disorder of liver function • Autoimmune diseases– autoantibodies against immunocompetent cells (neutrophils, lymphocytes) • Allergic diseases • ChronicGIT diseases, nephrotic syndrome • Malignant diseases(leukemia, lymphoma, myeloma) • Hypersplenism/asplenia, splenectomy – deficiency in generation of antibodies against encapsulated microorganisms(Pneumococcus, Neisseria) • Burn, postoperative status, injuries • Severe nutritional disorders, chronic stress • Drug induced immunodeficiencies(chemotherapy), immunosupression • Chronic exposureto harmfulchemical substances, ionizing radiation

  22. AIDS • Acquired ImmunoDeficiency Syndrom - caused by a retrovirus called human immunodeficiency virus - current incidence 40 mil.people, predominantly in central Africa, CZ – about 1000 infected people • viral transmission occurs through: - sexual intercourse - contact with blood - transplacentally, during the birth process or through a breast milk

  23. VIRUS HIV-1 • virion is consisted of a capside with marrow protein - p24 and RNA • RNA is copied into double-stranded DNA using reverse transcriptase • virus integrates to the human cell genome and arise a provirus • an activation of provirus leads to the replication of viral nuclear acid and genesis of a virion that goes through the cell membrane and caused the lysis of cell

  24. PRIMARY INFECTION • Infection - begins by HIV-1 with a tropism for macrofages: - the membrane molecules of dendritic cells bind glycoproteins on HIV-1 surface and transport viruses to the lymphatic nodes (LN), where activated T cells are infected viruses are replicated in the lymphatic nodes and transfer to the blood • features: malaise, fever, pain of muscles and joints, sweating, loss of appetite, vomiting, diarrhoea, rash, lymphadenopathy • Immunological findings: elevated C-reactive protein, lymphopenia, decrease of CD4+ cells • specific antibodies against HIV-1 don‘t generate • identification of viruses is performed by PCR or by the evidence of viral protein p24 presence

  25. ASYMPTOMATIC PERIODE • asymptomatic period – HIVs-1 with a tropism for macrophages are changed into viruses with a tropism for T cells and demage T cells (CD4+) • viruses replicate in cell secondary lymphatic organs - the period can last a several years • lasting depends on: - virus doses and virulence - an individual condition of immune system an infected person - an acceleration occures by repeated infection of different HIVs

  26. AIDS • AIDS- Related Complex (ARC) presents with lymphadenopathy and comes before fully developed AIDS • Clinical features of AIDS : - candidiasis of mouth and esophagous mucose, colpitis - oral leucoplakia, opportunistic infections - Kaposi sarcoma, non-Hodgkin‘s lymfoma

  27. VACCINE • development of a vaccine is unsuccessful due to: - unsuccesful searching for a dominant viral antigen - variability of the viruses HIV-1 in the course of time - absence of an animal experimental model (even the primate‘s infection course isn‘t identical with human)

  28. TREATMENT • Inhibitors of reverse transcriptase - 2 types + • Inhibitor of viral protease = • Therapy result to the inhibition of DNA synthesis, stop the progress of the disease and prolong the life of HIV infected persons

  29. IMMUNOGLOBULIN REPLACEMENT THERAPY Indication Contra-indication Adverse reaction

  30. IVIG is approved for treating • X-linked Bruton agammaglobulinemia • Common Variable ImmunoDeficiency • others

  31. CONTRA-INDICATIONS • Repeated severe side effects • Selective IgA deficiency with anaphylactic reaction to immunoglobuline • Severe acute infection

  32. IG ADMINISTRATION • Intramuscullar – maximum dose 1,5 g IgG/ week • Subcutaneous – total dose/month 400mg/kg, administration every week • Intravenous - 400 mg/kg/month

  33. AUTOIMMUNE DISORDERS examples

  34. CLINICAL CATEGORIES • systemic - affect many organs and tissue • organ localised - affect predominantly one organ accompained by affection of other organs (nonspecific bowel diseases, celiatic disease, AI hepatitis, pulmonary fibrosis) • organ specific - affect one organ or group of organs connected withdevelopment or function

  35. EXAMPLES OF SYSTEMIC AUTOIMMUNE DISEASES examples autoantibodies

  36. SYSTEMIC AUTOIMMUNE DISEASES • Systemic lupus erythematosus • Rheumathoid arthritis • Sjögren‘s syndrome • Dermatopolymyositis • Systemic sclerosis • Mixed connective tissue disease • Antiphospholipid syndrome • Vasculitis • Sarcoidosis

  37. SYSTEMIC LUPUS ERYTHEMATOSUS • chronic, inflammatory, multiorgan disorder • predominantly affects young women • autoantibodies react with nuclear material and attack cell function, immune complexes with dsDNA deposit in the tissue • general symptoms: include malaise, fever, weight loss • multiple tissueare involved including the skin, mucosa, kidney, joints, brain and cardiovascular system • characteristic features: butterfly rash, renal involvement, CNS manifestation, pulmonary fibrosis

  38. DIAGNOSTIC TESTS • a elevated ESR (erythrocyte sedimentation rate), low CRP, trombocytopenia, leukopenia, hemolytic anemia, depresed levels of complement (C4, C3), elevated serum gamma globulin levels

  39. AUTOANTIBODIES • Autoantibodies: ANA, dsDNA (double-stranged), ENA (SS-A/Ro, SS-A/La), Sm, against histones, phospholipids

  40. RHEUMATOID ARTHRITIS • chronic, inflammatory joint disease with systemic involvement • predominantly affects women • characterized by an inflammatory joint lesion in the synovial membrane, destruction of the cartilage and bone, results in the joint deformation • clinical features: arthritis, fever, fatigue, weakness, weight loss • systemic features: vasculitis, pericarditis, uveitis, nodules under skin, intersticial pulmonary fibrosis • diagnostic tests: elevated C- reactive protein and ESR, elevated serum gammaglobulin levels - autoantibodies against IgG = rheumatoid factor (RF), a-CCP (cyclic citrulline peptid), ANA - X-rays of hands and legs- show a periarticular porosis, marginal erosion

  41. Antiphospholipid syndrome • autoimmune disease characterized by vein and arterial thrombosis, repeated abortions • accompanied by anti-phospholipid autoantibodies (APA) and antibodies against β2-glykoprotein I

  42. EXAMPLES OF ORGAN- SPECIFIC AUTOIMMUNE DISEASES diseases autoantibodies

  43. ORGANOLEPTIC AUTOIMMUNE DISEASES • Ulcerative colitis • Crohn‘s disease • Coeliac disease • Autoimmune hepatitis • Primary biliary cirhosis • Primary sclerotic cholangoitis • Pulmonary fibrosis

  44. Ulcerative colitis • chronic inflammation of the large intestine mucose and submucose • features: diarrhea mixed with blood and mucus • extraintestinal features (artritis, uveitis) • autoantibodies against pANCA, a- large intestine

  45. Crohn‘s disease • the granulomatous inflammation of all intestinal wall with ulceration and scarring that can result in abscess and fistula formation • the inflammation of Crohn's disease the most commonly affects the terminal ileum, presents with diarrhea and is accompanied by extraintestinal features - iridocyclitis, uveitis, artritis, spondylitis • antibodies againstSaccharomyces cerevisiae (ASCA), a- pancreas

  46. Coeliac disease • a malabsorption syndrome characterized by marked atrophy and loss of function of the villi of the jejunum • inflammatory bowell disease arise from gliadin exposition • autoantibodies against endomysium, the most specific = tissue transglutaminaze; antibodies against gliadin are nonspecific • biopsy of the jejunum with findings of the villi atrophy

  47. ORGAN SPECIFIC AUTOIMMUNE DISEASES • Autoimmune endocrinopathy • Autoimmune neurological diseases • Autoimmune cytopenia • Autoimmune cutaneous diseases • Autoimmune eye diseases

  48. AUTOIMMUNE ENDOCRINOPATHY • Hashimoto‘s thyroiditis • Graves-Basedow disease • Postpartum thyroiditis • Diabetes mellitus I. type • Addison‘s disease • Autoimmune polyglandular syndrome • Pernicious anemia

  49. Hashimoto‘s thyroiditis • thyroid disease result to hypothyroidism on the base of lymphocytes and plasma cells infiltrate • autoantibodies against thyroidal peroxidase (a-TPO) and/or against thyroglobulin (a-TG)

  50. Grave‘s disease • thyrotoxicosis from overproduction of thyroid hormone (patient exhibit fatigue, nervousness, increased sweating, palpitations, weight loss, exophtalmos) • autoantibodies against thyrotropinreceptor, autoantibodies cause thyroid cells proliferation

More Related